GIM
ORGO icon

Granahan Investment Management’s Organogenesis Holdings ORGO Stock Holding History

Granahan Investment Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,973
Closed -$81K – 179
2022
Q3 		$81K Sell
24,973
-967,007
-97% -$4.37M ﹤0.01% 175
2022
Q2 		$4.84M Sell
991,980
-989,783
-50% -$6.09M 0.17% 118
2022
Q1 		$15.1M Sell
1,981,763
-267,827
-12% -$2.07M 0.37% 69
2021
Q4 		$20.8M Buy
2,249,590
+127,585
+6% +$1.36M 0.43% 62
2021
Q3 		$30.2M Buy
2,122,005
+13,553
+0.6% +$210K 0.57% 38
2021
Q2 		$35M Buy
2,108,452
+98,104
+5% +$1.83M 0.65% 38
2021
Q1 		$36.6M Buy
2,010,348
+521,863
+35% +$7.07M 0.78% 38
2020
Q4 		$11.2M Buy
1,488,485
+736,597
+98% +$3.5M 0.25% 84
2020
Q3 		$2.89M Buy
751,888
+401,608
+115% +$1.59M 0.1% 134
2020
Q2 		$1.34M Buy
350,280
+64,290
+22% +$232K 0.05% 163
2020
Q1 		$924K Buy
285,990
+35,990
+14% +$154K 0.05% 166
2019
Q4 		$1.2M Buy
+250,000
New +$1.58M 0.06% 155

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Granahan Investment Management's ORGO Position: Q4 2022 in Review

Granahan Investment Management sold out of Organogenesis Holdings (ORGO) in Q4 2022, closing a stake of 24,973 shares — an estimated $81K sold.

Granahan Investment Management first reported a position in ORGO in Q4 2019 and held it in 12 quarters. The position peaked at $36.6M in Q1 2021. 150 funds tracked by Wall St. Rank hold ORGO as of Q4 2022.

  • Granahan Investment Management reported no remaining Organogenesis Holdings position as of Q4 2022 after selling out during the quarter.
  • Granahan Investment Management sold 24,973 Organogenesis Holdings shares in Q4 2022, an estimated $81K.
  • Granahan Investment Management first reported a position in Organogenesis Holdings in Q4 2019 and held it in 12 quarters.
  • Granahan Investment Management's Organogenesis Holdings position peaked at $36.6M in Q1 2021.
  • 150 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2022.

Based on Granahan Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.